{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:29:01Z","timestamp":1793158141059,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal, neurodegenerative motor neuron disease. Although an early diagnosis is crucial to provide adequate care and improve survival, patients with ALS experience a significant diagnostic delay. This study aimed to use real-world data to describe the clinical profile and timing between symptom onset, diagnosis, and relevant outcomes in ALS. Retrospective and multicenter study in 5 representative hospitals and Primary Care services in the SESCAM Healthcare Network (Castilla-La Mancha, Spain). Using Natural Language Processing (NLP), the clinical information in electronic health records of all patients with ALS was extracted between January 2014 and December 2018. From a source population of all individuals attended in the participating hospitals, 250 ALS patients were identified (61.6% male, mean age 64.7\u00a0years). Of these, 64% had spinal and 36% bulbar ALS. For most defining symptoms, including dyspnea, dysarthria, dysphagia and fasciculations, the overall diagnostic delay from symptom onset was 11 (6\u201318) months. Prior to diagnosis, only 38.8% of patients had visited the neurologist. In a median post-diagnosis follow-up of 25\u00a0months, 52% underwent gastrostomy, 64% non-invasive ventilation, 16.4% tracheostomy, and 87.6% riluzole treatment; these were more commonly reported (all Ps\u2009&lt;\u20090.05) and showed greater probability of occurrence (all Ps\u2009&lt;\u20090.03) in bulbar ALS. Our results highlight the diagnostic delay in ALS and revealed differences in the clinical characteristics and occurrence of major disease-specific events across ALS subtypes. NLP holds great promise for its application in the wider context of rare neurological diseases.<\/jats:p>","DOI":"10.1038\/s41598-023-27863-2","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T11:10:38Z","timestamp":1673608238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Symptoms timeline and outcomes in amyotrophic lateral sclerosis using artificial intelligence"],"prefix":"10.1038","volume":"13","author":[{"given":"Tom\u00e1s","family":"Segura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio H.","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Collazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Mat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Sguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Del Rio-Bermudez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Casero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Salcedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Alcahut-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Savana Research Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Aquino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Casadevall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Donaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Marin-Corral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Menke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Polo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miren","family":"Taberna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"27863_CR1","first-page":"303","volume":"9","author":"K Talbot","year":"2009","unstructured":"Talbot, K. Motor neuron disease. Bare Essentials 9, 303\u2013309 (2009).","journal-title":"Bare Essentials"},{"key":"27863_CR2","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"key":"27863_CR3","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","volume":"344","author":"LP Rowland","year":"2001","unstructured":"Rowland, L. P. & Shneider, N. A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 344, 1688\u20131700 (2001).","journal-title":"N. Engl. J. Med."},{"key":"27863_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3109\/17482960802566824","volume":"10","author":"A Chi\u00f2","year":"2009","unstructured":"Chi\u00f2, A. et al. Prognostic factors in ALS: A critical review. Amyotroph. Lateral Scler. 10, 310\u2013323 (2009).","journal-title":"Amyotroph. Lateral Scler."},{"key":"27863_CR5","unstructured":"Charcot, J. & Joffroy, A. Deux Cas d Atrophie Musculaire Progressive Avec Lesions de La substance Grise et des Faisceaux Antero-Lateraux de la Moelle Epiniere."},{"key":"27863_CR6","first-page":"S53","volume":"53","author":"BR Brooks","year":"1999","unstructured":"Brooks, B. R. Earlier is better: The benefits of early diagnosis. Neurology 53, S53-54 (1999) (discussion S55-57).","journal-title":"Neurology"},{"key":"27863_CR7","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/WCO.0000000000000730","volume":"32","author":"E Longinetti","year":"2019","unstructured":"Longinetti, E. & Fang, F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr. Opin. Neurol. 32, 771\u2013776 (2019).","journal-title":"Curr. Opin. Neurol."},{"key":"27863_CR8","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari, A. et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 3, 1335\u20131342 (2017).","journal-title":"JAMA Oncol."},{"key":"27863_CR9","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1097\/MEG.0000000000002317","volume":"34","author":"F Gomoll\u00f3n","year":"2020","unstructured":"Gomoll\u00f3n, F. et al. Clinical characteristics and prognostic factors for Crohn\u2019s disease relapses using natural language processing and machine learning: A pilot study. Eur. J. Gastroenterol. Hepatol. 34, 389\u2013397 (2020).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"27863_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40545-020-00276-6","volume":"13","author":"CM Del Rio-Bermudez","year":"2020","unstructured":"Del Rio-Bermudez, C. M. et al. Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy. J. Pharm. Policy Pract. 13, 1\u20136 (2020).","journal-title":"J. Pharm. Policy Pract."},{"key":"27863_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0263277","volume":"17","author":"C Gonz\u00e1lez-Juanatey","year":"2022","unstructured":"Gonz\u00e1lez-Juanatey, C. et al. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing. PLoS ONE 17, e0263277 (2022).","journal-title":"PLoS ONE"},{"key":"27863_CR12","doi-asserted-by":"publisher","DOI":"10.2196\/12239","volume":"7","author":"S Sheikhalishahi","year":"2019","unstructured":"Sheikhalishahi, S. et al. Natural language processing of clinical notes on chronic diseases: Systematic review. JMIR Med. Inform. 7, e12239 (2019).","journal-title":"JMIR Med. Inform."},{"key":"27863_CR13","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/jamia\/ocw042","volume":"24","author":"BA Goldstein","year":"2017","unstructured":"Goldstein, B. A., Navar, A. M., Pencina, M. J. & Ioannidis, J. P. Opportunities and challenges in developing risk prediction models with electronic health records data: A systematic review. J. Am. Med. Inform. Assoc. 24, 198\u2013208 (2017).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"27863_CR14","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s40264-017-0558-6","volume":"40","author":"Y Luo","year":"2017","unstructured":"Luo, Y. et al. Natural language processing for EHR-based pharmacovigilance: A structured review. Drug Saf. 40, 1075\u20131089 (2017).","journal-title":"Drug Saf."},{"key":"27863_CR15","first-page":"425","volume":"43","author":"JL Izquierdo","year":"2020","unstructured":"Izquierdo, J. L. et al. The impact of COVID-19 on patients with asthma. Eur. Respir. J. 43, 425 (2020).","journal-title":"Eur. Respir. J."},{"key":"27863_CR16","doi-asserted-by":"publisher","DOI":"10.2196\/21801","volume":"22","author":"JL Izquierdo","year":"2020","unstructured":"Izquierdo, J. L., Ancochea, J. & Soriano, J. B. Clinical characteristics and prognostic factors for intensive care unit admission of patients with COVID-19: Retrospective study using machine learning and natural language processing. J. Med. Internet Res. 22, e21801 (2020).","journal-title":"J. Med. Internet Res."},{"key":"27863_CR17","first-page":"8","volume":"4","author":"ITG Hernandez Medrano","year":"2017","unstructured":"Hernandez Medrano, I. T. G. et al. Savana: Re-using electronic health records with artificial intelligence. Int. J. Interact. Multimed. Artif. Intell. 4, 8\u201312 (2017).","journal-title":"Int. J. Interact. Multimed. Artif. Intell."},{"key":"27863_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1089\/jwh.2020.8721","volume":"30","author":"J Ancochea","year":"2020","unstructured":"Ancochea, J. et al. Evidence of gender differences in the diagnosis and management of COVID-19 patients: An analysis of electronic health records using natural language processing and machine learning. J. Women Health 30, 393\u2013404 (2020).","journal-title":"J. Women Health"},{"key":"27863_CR19","doi-asserted-by":"publisher","DOI":"10.2196\/20492","volume":"9","author":"L Canales","year":"2021","unstructured":"Canales, L. et al. Assessing the performance of clinical natural language processing systems: Development of an evaluation methodology. JMIR Med. Inform. 9, e20492 (2021).","journal-title":"JMIR Med. Inform."},{"key":"27863_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"BR Brooks","year":"1994","unstructured":"Brooks, B. R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases\/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial \u201cClinical limits of amyotrophic lateral sclerosis\u201d workshop contributors. J. Neurol. Sci. 124, 96\u2013107 (1994).","journal-title":"J. Neurol. Sci."},{"key":"27863_CR21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/146608200300079536","volume":"1","author":"BR Brooks","year":"2000","unstructured":"Brooks, B. R., Miller, R. G., Swash, M. & Munsat, T. L. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1, 293\u2013299 (2000).","journal-title":"Amyotroph. Lateral Scler. Other Motor Neuron Disord."},{"key":"27863_CR22","first-page":"23","volume":"57","author":"LT Espinosa-Anke","year":"2016","unstructured":"Espinosa-Anke, L. T. et al. Savana: A global information extraction and terminology expansion framework in the medical domain Procesamiento del Lenguaje. Natural 57, 23\u201330 (2016).","journal-title":"Natural"},{"key":"27863_CR23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1080\/21678421.2018.1497065","volume":"19","author":"E Longinetti","year":"2018","unstructured":"Longinetti, E. et al. The Swedish motor neuron disease quality registry. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 528\u2013537 (2018).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"27863_CR24","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/21678421.2018.1511732","volume":"20","author":"F Palese","year":"2019","unstructured":"Palese, F. et al. Epidemiology of amyotrophic lateral sclerosis in Friuli-Venezia Giulia, North-Eastern Italy, 2002\u20132014: A retrospective population-based study. Amyotroph. Lateral Scler. Frontotemporal Degener. 20, 90\u201399 (2019).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"27863_CR25","doi-asserted-by":"publisher","first-page":"102158","DOI":"10.1016\/j.aprim.2021.102158","volume":"53","author":"E Castro-Rodr\u00edguez","year":"2021","unstructured":"Castro-Rodr\u00edguez, E., Azagra, R., G\u00f3mez-Batiste, X. & Povedano, M. Amyotrophic lateral sclerosis (ALS) from the perspective of primary care. Epidemiology and clinical-care characteristics. Aten Primaria 53, 102158 (2021).","journal-title":"Aten Primaria"},{"key":"27863_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1136\/jnnp-2018-318974","volume":"90","author":"KY Jun","year":"2019","unstructured":"Jun, K. Y. et al. Epidemiology of ALS in Korea using nationwide big data. J. Neurol. Neurosurg. Psychiatry 90, 395\u2013403 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"27863_CR27","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1080\/21678421.2018.1513534","volume":"19","author":"E Benjaminsen","year":"2018","unstructured":"Benjaminsen, E., Alstadhaug, K. B., Gulsvik, M., Baloch, F. K. & Odeh, F. Amyotrophic lateral sclerosis in Nordland county, Norway, 2000\u20132015: Prevalence, incidence, and clinical features. Amyotroph. Lateral Scler. Frontotemporal Degener. 19, 522\u2013527 (2018).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"27863_CR28","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1136\/jnnp.55.12.1116","volume":"55","author":"RJ Swingler","year":"1992","unstructured":"Swingler, R. J., Fraser, H. & Warlow, C. P. Motor neuron disease and polio in Scotland. J. Neurol. Neurosurg. Psychiatry 55, 1116\u20131120 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"27863_CR29","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/ene.12015","volume":"20","author":"S K\u00f6rner","year":"2013","unstructured":"K\u00f6rner, S. et al. Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur. J. Neurol. 20, 647\u2013654 (2013).","journal-title":"Eur. J. Neurol."},{"key":"27863_CR30","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1007\/s00415-020-09799-z","volume":"267","author":"K Diekmann","year":"2020","unstructured":"Diekmann, K. et al. Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group. J. Neurol. 267, 2130\u20132141 (2020).","journal-title":"J. Neurol."},{"key":"27863_CR31","doi-asserted-by":"publisher","first-page":"604922","DOI":"10.3389\/fneur.2020.604922","volume":"11","author":"M Mart\u00ednez-Molina","year":"2020","unstructured":"Mart\u00ednez-Molina, M. et al. Early referral to an ALS center reduces several months the diagnostic delay: A multicenter-based study. Front. Neurol. 11, 604922 (2020).","journal-title":"Front. Neurol."},{"key":"27863_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.761355","volume":"12","author":"C Falc\u00e3o de Campos","year":"2021","unstructured":"Falc\u00e3o de Campos, C. et al. Delayed diagnosis and diagnostic pathway of ALS patients in Portugal: Where can we improve?. Front Neurol 12, 761355 (2021).","journal-title":"Front Neurol"},{"key":"27863_CR33","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.nrl.2018.03.026","volume":"36","author":"JF V\u00e1zquez-Costa","year":"2021","unstructured":"V\u00e1zquez-Costa, J. F. et al. Analysis of the diagnostic pathway and delay in patients with amyotrophic lateral sclerosis in the Valencian Community. Neurologia 36, 504\u2013513 (2021).","journal-title":"Neurologia"},{"key":"27863_CR34","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1471-2377-13-19","volume":"13","author":"O Kano","year":"2013","unstructured":"Kano, O. et al. Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset. BMC Neurol. 13, 19 (2013).","journal-title":"BMC Neurol."},{"key":"27863_CR35","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1038\/550S115a","volume":"550","author":"N Savage","year":"2017","unstructured":"Savage, N. Calculating disease. Nature 550, S115\u2013S117 (2017).","journal-title":"Nature"},{"key":"27863_CR36","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1111\/ene.14647","volume":"28","author":"S Spittel","year":"2021","unstructured":"Spittel, S. et al. Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in Germany. Eur. J. Neurol. 28, 1160\u20131171 (2021).","journal-title":"Eur. J. Neurol."},{"key":"27863_CR37","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s00415-016-8313-y","volume":"264","author":"A Calvo","year":"2017","unstructured":"Calvo, A. et al. Factors predicting survival in ALS: A multicenter Italian study. J. Neurol. 264, 54\u201363 (2017).","journal-title":"J. Neurol."},{"key":"27863_CR38","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1080\/21678421.2017.1317812","volume":"18","author":"P Ceriana","year":"2017","unstructured":"Ceriana, P., Surbone, S., Segagni, D., Schreiber, A. & Carlucci, A. Decision-making for tracheostomy in amyotrophic lateral sclerosis (ALS): a retrospective study. Amyotroph. Lateral Scler. Frontotemporal Degener 18, 492\u2013497 (2017).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener"},{"key":"27863_CR39","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1136\/jnnp.2009.175984","volume":"81","author":"A Chi\u00f2","year":"2010","unstructured":"Chi\u00f2, A. et al. Tracheostomy in amyotrophic lateral sclerosis: A 10-year population-based study in Italy. J. Neurol. Neurosurg. Psychiatry 81, 1141\u20131143 (2010).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"27863_CR40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0022-510X(99)00228-2","volume":"169","author":"J Melo","year":"1999","unstructured":"Melo, J. et al. Pulmonary evaluation and prevalence of non-invasive ventilation in patients with amyotrophic lateral sclerosis: A multicenter survey and proposal of a pulmonary protocol. J. Neurol. Sci. 169, 114\u2013117 (1999).","journal-title":"J. Neurol. Sci."},{"key":"27863_CR41","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/jnnp.2006.103564","volume":"78","author":"CL Shoesmith","year":"2007","unstructured":"Shoesmith, C. L., Findlater, K., Rowe, A. & Strong, M. J. Prognosis of amyotrophic lateral sclerosis with respiratory onset. J. Neurol. Neurosurg. Psychiatry 78, 629\u2013631 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"27863_CR42","first-page":"CD001447","volume":"2002","author":"RG Miller","year":"2002","unstructured":"Miller, R. G., Mitchell, J. D., Lyon, M. & Moore, D. H. Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst. Rev. 2002, CD001447 (2002).","journal-title":"Cochrane Database Syst. Rev."},{"key":"27863_CR43","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1080\/21678421.2020.1771734","volume":"21","author":"JA Andrews","year":"2020","unstructured":"Andrews, J. A. et al. Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 21, 509\u2013518 (2020).","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"27863_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3389\/fnins.2019.00135","volume":"13","author":"V Grollemund","year":"2019","unstructured":"Grollemund, V. et al. Machine learning in amyotrophic lateral sclerosis: Achievements, pitfalls, and future directions. Front. Neurosci. 13, 135\u2013135 (2019).","journal-title":"Front. Neurosci."},{"key":"27863_CR45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244604","volume":"16","author":"S Cardoso","year":"2021","unstructured":"Cardoso, S. et al. Use of a modular ontology and a semantic annotation tool to describe the care pathway of patients with amyotrophic lateral sclerosis in a coordination network. PLoS ONE 16, e0244604 (2021).","journal-title":"PLoS ONE"},{"key":"27863_CR46","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1001\/jama.2013.393","volume":"309","author":"TB Murdoch","year":"2013","unstructured":"Murdoch, T. B. & Detsky, A. S. The inevitable application of big data to health care. JAMA 309, 1351\u20131352 (2013).","journal-title":"JAMA"},{"key":"27863_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40545-020-00276-6","volume":"13","author":"C Del Rio-Bermudez","year":"2020","unstructured":"Del Rio-Bermudez, C., Medrano, I. H., Yebes, L. & Poveda, J. L. Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy. J. Pharm. Policy Pract. 13, 75 (2020).","journal-title":"J. Pharm. Policy Pract."},{"key":"27863_CR48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12883-017-0854-x","volume":"17","author":"C Schuster","year":"2017","unstructured":"Schuster, C., Hardiman, O. & Bede, P. Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurol. 17, 73 (2017).","journal-title":"BMC Neurol."},{"key":"27863_CR49","doi-asserted-by":"publisher","first-page":"e2114723","DOI":"10.1001\/jamanetworkopen.2021.14723","volume":"4","author":"Q Yuan","year":"2021","unstructured":"Yuan, Q. et al. Performance of a machine learning algorithm using electronic health record data to identify and estimate survival in a longitudinal cohort of patients with lung cancer. JAMA Netw. Open 4, e2114723\u2013e2114723 (2021).","journal-title":"JAMA Netw. Open"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27863-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27863-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T11:20:10Z","timestamp":1673608810000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-27863-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["27863"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-27863-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"assertion":[{"value":"26 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"702"}}